Peptides for Athletes

In this episode of HSS Presents, Dr. Scott Rodeo, Director of the Center for Regenerative Medicine at HSS, talks with sports medicine surgeon Dr. Yianni Apostolakos about the massive public interest and clinical realities surrounding Body Protection Compound 157 (BPC-157). Prompted by a widely read systematic review, the experts contrast promising preclinical animal data with the current lack of robust, human clinical trials. They discuss the shifting regulatory landscape—including recent FDA updates on compounding restrictions—and explain why these substances remain banned by WADA and major sports leagues. This conversation provides evidence for clinicians looking to ethically counsel both elite and recreational athletes on the use of these substances. Read the HSS Journal systematic review: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.